by
CDMO
//
January 5, 2026
More Details
CDMO World has established a new media partnership with Chem Outsourcing to collaborate on editorial coverage, industry insights, and expanded visibility for organizations operating across the pharmaceutical, biotechnology, and specialty chemical outsourcing ecosystem.
by
CDMO
//
January 2, 2026
More Details
Sharp Services is investing in its Macungie, Pennsylvania facility to expand sterile injectable manufacturing capacity, aligning with growing CDMO outsourcing trends and regulatory demands.
by
CDMO World
//
December 27, 2025
More Details
Kazia’s EVT801 Phase 1 trial success highlights critical CDMO roles in scale-up, regulatory alignment, supply chain management and partnership models.
by
CDMO World
//
December 27, 2025
More Details
Bayer and Evotec’s renewed focus on precision cardiology drives new CDMO opportunities in manufacturing scale, regulatory alignment, supply chain resilience and advanced technology adoption.
by
CDMO World
//
December 27, 2025
More Details
Evotec Biologics introduces the J.CHO™ High Expression System for continuous antibody production, offering CDMOs enhanced productivity, scalability and quality control.
by
CDMO World
//
December 27, 2025
More Details
Evotec SE’s appointment of Dr Christian Wojczewski as CEO offers strategic direction for its CDMO services, impacting manufacturing capacity, outsourcing trends and market positioning.
by
CDMO World
//
December 26, 2025
More Details
Explore how the recent collaboration between Evotec and Variant Bio to develop fibrosis treatments creates opportunities and challenges for CDMOs in talent, capacity, supply chain, and regulatory processes.
by
CDMO World
//
December 26, 2025
More Details
Evotec SE will release its 2023 financial results on April 24, 2024. CDMO stakeholders should assess the outcomes for insights on outsourcing demand, manufacturing capacity expansion, regulatory alignment and strategic partnerships.
by
CDMO World
//
December 25, 2025
More Details
Aurélie Dalbiez joins Evotec as Chief People Officer on June 15, 2024, to enhance talent strategies, workforce capacity and organizational culture across the company’s CDMO operations.
by
CDMO World
//
December 25, 2025
More Details
Etherna expands its CDMO offerings in the US by appointing Shelly West as Business Development Director, driving mRNA partnerships and GMP manufacturing growth.
by
CDMO World
//
December 25, 2025
More Details
Exothera has extended its world-first continuous-batch RNA manufacturing solution into North America, offering CDMOs automated, integrated production to accelerate clinical timelines, enhance yield and streamline regulatory compliance.
by
CDMO World
//
December 25, 2025
More Details
Breakpoint Therapeutics’ nomination of BTX-011 highlights critical CDMO opportunities in process development, manufacturing and regulatory support for DDR-targeting oncology drugs.
by
CDMO World
//
December 25, 2025
More Details
Tubulis’ €128 million Series B2 financing will fuel its solid tumor ADC pipeline and drive increased CDMO engagement in capacity expansion, outsourcing, and advanced manufacturing.
by
CDMO World
//
December 24, 2025
More Details
Evotec SE and Claris Ventures launch a framework to streamline portfolio biotech programmes through an integrated CDMO platform, boosting manufacturing efficiency, regulatory alignment, and outsourcing strategies within the pharma industry.
by
CDMO World
//
December 24, 2025
More Details
Symbiosis has been honored with the beMaster Plus award for build excellence in exhibition stand construction. This recognition offers key insights for CDMO companies aiming to elevate their trade show presence through modular design, regulatory alignment and sustainable practices.
by
CDMO World
//
December 24, 2025
More Details
This article examines the partnership between Evotec and Helmholtz Institute, exploring how CDMOs facilitate the development, scale-up, and manufacturing of novel anti-infectives against tuberculosis and malaria.
by
CDMO World
//
December 24, 2025
More Details
A recent peer-reviewed paper from etherna demonstrates enhanced immune response and reduced reactogenicity of LNP-based mRNA vaccines, signaling new growth avenues for CDMOs specializing in lipid nanoparticle manufacturing and biologics scale-up.
by
CDMO World
//
December 23, 2025
More Details
Explore how standardized viral vector platforms enable CDMOs to improve process efficiency, regulatory compliance, and capacity scalability in gene therapy production.
by
CDMO World
//
December 23, 2025
More Details
Just – Evotec Biologics has deepened its development and manufacturing agreement with Advanced BioScience Laboratories (ABL), advancing CDMO capabilities for broadly neutralising HIV antibodies.
by
CDMO World
//
December 23, 2025
More Details
Sharp Services, a leader in pharmaceutical packaging and clinical trial supply, has joined the Science Based Targets initiative to drive greenhouse gas reductions. Discover CDMO-specific sustainability tactics for operational efficiency and regulatory compliance.
by
CDMO World
//
December 23, 2025
More Details
Evotec SE’s upcoming conference call on January 22, 2024, will provide a business update with significant CDMO implications, covering outsourcing strategies, manufacturing capacity, and emerging market trends.
by
CDMO World
//
December 23, 2025
More Details
An in-depth examination of modern scalable bioreactor platforms and their strategic role in CDMO-driven gene and cell therapy manufacturing.
by
CDMO World
//
December 22, 2025
More Details
A detailed guide for CDMOs on designing robust stable cell line strategies for gene and cell therapy manufacturing, covering technical, regulatory, and operational considerations.
by
CDMO World
//
December 22, 2025
More Details
Evotec’s alliance with the Crohn’s & Colitis Foundation signals intensified CDMO engagement in IBD drug development, highlighting opportunities in outsourcing, manufacturing scale-up, technology integration, and regulatory alignment.
by
CDMO World
//
December 22, 2025
More Details
Evotec’s latest $25 million funding milestone with Bristol Myers Squibb highlights critical trends in neuroscience contract development and manufacturing, underscoring investment shifts, capacity demands, and regulatory alignments in the CDMO sector.
by
CDMO World
//
December 22, 2025
More Details
Evotec and Owkin’s AI-integrated collaboration in oncology and I&I is poised to reshape CDMO outsourcing strategies, drive demand for advanced manufacturing services, and accelerate biologics development.
by
CDMO World
//
December 21, 2025
More Details
Evotec’s CEO transition prompts analysis of impacts on CDMO partnerships, manufacturing capacity and strategic outsourcing.
by
CDMO World
//
December 21, 2025
More Details
Evotec’s CEO transition prompts analysis of impacts on CDMO partnerships, manufacturing capacity and strategic outsourcing.
by
CDMO World
//
December 21, 2025
More Details
Evotec’s CEO transition prompts analysis of impacts on CDMO partnerships, manufacturing capacity and strategic outsourcing.
by
CDMO World
//
December 21, 2025
More Details
Evotec’s CEO departure signals shifts in CDMO partnerships, capacity planning and outsourcing strategies, shaping the contract development landscape.
by
CDMO World
//
December 20, 2025
More Details
Evotec has been awarded a US$2.5M grant by the Bill & Melinda Gates Foundation to support its human iPSC-derived teratogenicity testing platform, underscoring key considerations for CDMO outsourcing strategies, capacity management, and regulatory alignment in global health product development.
by
CDMO World
//
December 20, 2025
More Details
Valuations in the healthcare ecosystem are rarely one-size-fits-all. While all healthcare businesses operate under regulatory oversight and long development cycles, the financial logic used to value a biotech startup is
by
prateek
//
December 20, 2025
More Details
Evotec’s collaboration with Charité to develop a molecular database for ANCA-associated vasculitis reshapes CDMO approaches to data-driven development, outsourcing strategies, and manufacturing capacity in autoimmune therapeutics.
by
CDMO World
//
December 20, 2025
More Details
A deep dive into how the Almirall-etherna mRNA dermatology collaboration influences CDMO capacity, technology transfer, regulatory and supply chain dynamics.
by
CDMO World
//
December 19, 2025
More Details
Zhejiang Jingxin Pharma’s NMPA approval for EVT201 underscores emerging opportunities and challenges for CDMO providers in capacity planning, supply chain optimization, and regulatory alignment.
by
CDMO World
//
December 19, 2025
More Details
Evotec SE has expanded its $20M beLAB1407 BRIDGE partnership with Bristol Myers Squibb to onboard the Universities of Bristol and Glasgow, and Queen Mary University of London, unlocking new CDMO opportunities in contract development, biologics manufacturing and regulatory alignment.
by
CDMO World
//
December 19, 2025
More Details
Evotec SE’s precision medicine platforms showcased at Capital Markets Day have major implications for CDMOs in areas from contract development to digital manufacturing and strategic partnerships.
by
CDMO World
//
December 19, 2025
More Details
Evotec SE’s nine-month 2023 financial results highlight key trends and strategies shaping the CDMO landscape, from capacity expansion to technological innovation.
by
CDMO World
//
December 19, 2025
More Details
Evotec’s recent approval from the Science Based Targets initiative for near term emissions goals underscores a growing sustainability focus within the CDMO industry. Discover how contract development and manufacturing organizations can leverage this momentum through capacity planning, supply chain optimization, and green technology adoption.
by
CDMO World
//
December 18, 2025
More Details
Sponsored By & Strategic Partners
BioManufacturing
CDMO Excellence
QualityFirst
GMP Consulting
TechTransfer
Process Optimization
SCxCMC
Supply Chain x CMC Solutions
GlobalRegulatory
Worldwide Compliance Experts
PharmaLogistics
Cold Chain Specialists
BioManufacturing
CDMO Excellence
QualityFirst
GMP Consulting
TechTransfer
Process Optimization
SCxCMC
Supply Chain x CMC Solutions
GlobalRegulatory
Worldwide Compliance Experts
PharmaLogistics
Cold Chain Specialists
Rising Stars in the CDMO World
Meet the innovators shaping the future of pharmaceutical manufacturing
Dr. Maya Chen
Principal Scientist, Cell & Gene Therapy
NextGen Biologics
Pioneering AI-driven cell line optimization reducing development timelines by 40%
-
Cell Line Development
-
Process Analytics
View Profile
James Rodriguez
CEO & President
BioPrecision Manufacturing
Built $200M CDMO from startup to 500+ employees in 5 years serving 40+ biotech clients
-
Strategic Growth
-
Client Relations
View Profile
Sarah Nakamura
Founder & CSO
Modular Pharma Systems
Revolutionary modular manufacturing platform enabling rapid CDMO capacity expansion
-
Facility Design
-
Modular Systems
View Profile
Alex Thompson
VP of Technology
SmartManufacture AI
Developed predictive analytics platform used by 15+ major CDMOs for real-time process optimization
-
Software Development
-
Machine Learning
View Profile
-
Funding & Financial Resourcesv
Capital to Fuel Your Innovation
Connect with investors and funding opportunities to accelerate your pharmaceutical
development
BioPharma Ventures Capital
Leading life sciences investment firm focused on early to mid-stage biotech companies. Actively seeking novel therapeutics in oncology, rare diseases, and cell & gene therapy. $500M+ fund with deep industry expertise.
-
Series A-C
-
Oncology Focus
-
Cell & Gene Therapy
$5M – $50M
Per portfolio company
Pitch Your Technology
Infectious Disease Research Initiative
Annual grant program supporting innovative research in infectious disease therapeutics and vaccine development. Also funding facility expansion for GMP manufacturing capabilities focused on rapid response production.
-
Disease Research
-
Facility Building
-
GMP Manufacturing
Up to $10M
Multi-year funding available
Application Deadline: March 15, 2025
View Grant Details
Banc of California
Regional bank with dedicated life sciences and healthcare investment division. Providing growth capital, equipment financing, and strategic banking services to emerging biotech and pharmaceutical companies across California.
-
Growth Capital
-
Equipment Financing
-
Banking Services
$2M – $25M
Flexible terms available
Connect with Our Team
Incubators & Manufacturing Support
Launch and scale your biotech venture with expert guidance, infrastructure, and
resources
Altitude Labs
Premier life sciences incubator and CDMO services provider offering wet lab space, manufacturing support, and business development guidance for early-stage biotech companies.
-
Contract Research
-
Analytical Services
-
Preclinical Development
Apply Now
Altitude Labs
Premier life sciences incubator and CDMO services provider offering wet lab space, manufacturing support, and business development guidance for early-stage biotech companies.
-
Contract Research
-
Analytical Services
-
Preclinical Development
Apply Now
Altitude Labs
Premier life sciences incubator and CDMO services provider offering wet lab space, manufacturing support, and business development guidance for early-stage biotech companies.
-
Contract Research
-
Analytical Services
-
Preclinical Development
Apply Now
Altitude Labs
Premier life sciences incubator and CDMO services provider offering wet lab space, manufacturing support, and business development guidance for early-stage biotech companies.
-
Contract Research
-
Analytical Services
-
Preclinical Development
Apply Now
Exclusive Video Content
Inside the CDMO World
Get exclusive access to industry insights with expert interviews and facility tours
Dr. James Chen
VP of Operations, BioPharma Solutions
Watch Now
Dr. James Chen
VP of Operations, BioPharma Solutions
Watch Now
View All Exclusive Videos
Resource Library
Actionable Tools & Premium Resources
Download peer-reviewed checklists, templates, and industry reports trusted by
pharmaceutical decision-makers worldwide.
eBook
2025 Cold-Chain Logistics Guide
Complete guide to temperature-controlled distribution for biologics and cell therapies.
-
Biologics
-
Logistics
-
Cold Chain
Download
Webinar Series
GMP Facility Design Masterclass
6-part webinar series on designing state-of-the-art pharmaceutical facilities.
-
GMP
-
Facility Design
-
Compliance
Learn More
Templates
Process Validation Template Pack
Pre-built templates for IQ, OQ, PQ documentation and process validation protocols.
-
Quality
-
Validation
-
Templates
Buy Now
Checklist
CDMO Selection Framework
Strategic framework for evaluating and selecting the right CDMO partner.
Buy Now
Browse Full Library
Pharma Problem Solved
Expert consultants tackle real-world pharmaceutical manufacturing challenges with
actionable solutions and proven strategies.
Scaling Biologics Manufacturing from 200L to 2000L
Dr. James Chen
VP of Operations, BioPharma Solutions
Watch Now
Navigating FDA 483 Responses: A Strategic Approach
Dr. James Chen
VP of Operations, BioPharma Solutions
Watch Now
Cold Chain Validation: End-to-End Temperature Control
Dr. James Chen
VP of Operations, BioPharma Solutions
Watch Now
Implementing Real-Time Release Testing (RTRT)
Dr. James Chen
VP of Operations, BioPharma Solutions
Watch Now
View All Videos
Our Spotlights
Handpicked solutions and experts to elevate your pharmaceutical operations
Featured Consultant
Val – Pharmaceutical Excellence
Industry veteran with 25+ years of expertise in CDMO operations, regulatory compliance, and manufacturing optimization. Specialized in biologics manufacturing and global regulatory strategy.
-
CDMO Strategy
-
Regulatory Expert
-
Biologics Manufacturing
View Consultant Profile
Featured Consultant
Val – Pharmaceutical Excellence
Industry veteran with 25+ years of expertise in CDMO operations, regulatory compliance, and manufacturing optimization. Specialized in biologics manufacturing and global regulatory strategy.
-
CDMO Strategy
-
Regulatory Expert
-
Biologics Manufacturing
View Consultant Profile
Featured Consultant
Val – Pharmaceutical Excellence
Industry veteran with 25+ years of expertise in CDMO operations, regulatory compliance, and manufacturing optimization. Specialized in biologics manufacturing and global regulatory strategy.
-
CDMO Strategy
-
Regulatory Expert
-
Biologics Manufacturing
View Consultant Profile
Featured Consultant
Val – Pharmaceutical Excellence
Industry veteran with 25+ years of expertise in CDMO operations, regulatory compliance, and manufacturing optimization. Specialized in biologics manufacturing and global regulatory strategy.
-
CDMO Strategy
-
Regulatory Expert
-
Biologics Manufacturing
View Consultant Profile
Incoming Project Requests
Real-time opportunities from companies seeking specialized services
Implementing Real-Time Release Testing (RTRT)
Seeking experienced international trade attorney specializing in pharmaceutical exports to EU and Asian markets. Need expertise in regulatory compliance and
Submit Proposal
Implementing Real-Time Release Testing (RTRT)
Seeking experienced international trade attorney specializing in pharmaceutical exports to EU and Asian markets. Need expertise in regulatory compliance and
Submit Proposal
Implementing Real-Time Release Testing (RTRT)
Seeking experienced international trade attorney specializing in pharmaceutical exports to EU and Asian markets. Need expertise in regulatory compliance and
Submit Proposal
Implementing Real-Time Release Testing (RTRT)
Seeking experienced international trade attorney specializing in pharmaceutical exports to EU and Asian markets. Need expertise in regulatory compliance and
Submit Proposal
Implementing Real-Time Release Testing (RTRT)
Seeking experienced international trade attorney specializing in pharmaceutical exports to EU and Asian markets. Need expertise in regulatory compliance and
Submit Proposal
Implementing Real-Time Release Testing (RTRT)
Seeking experienced international trade attorney specializing in pharmaceutical exports to EU and Asian markets. Need expertise in regulatory compliance and
Submit Proposal
View All Project Requests
Submit Project Request